Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 19 - Drugs for skeletal disorders
Patents for A61P 19 - Drugs for skeletal disorders (81,981)
10/2012
10/31/2012CN102755669A Preparation method and application of fibrin glue composite recombinant human bone morphogenetic protein-2 (rhBMP-2) microsphere
10/31/2012CN102755646A Medicament for treating TNF alpha related disorder
10/31/2012CN102755633A Application of human recombinant protein PDCD5 to treatment of autoimmune disease
10/31/2012CN102755622A Medicine for treating rheumatoid arthritis
10/31/2012CN102755598A Medicine for treating acute gouty arthritis and preparation method thereof
10/31/2012CN102755595A Bone fracture medicinal patch and preparation method thereof
10/31/2012CN102755591A Chinese medicinal plaster for treating bone fracture
10/31/2012CN102755571A Medicinal liquor and preparation process for treating rheumatism and rheumatoid
10/31/2012CN102755545A Traditional Chinese medicine for increasing height of people
10/31/2012CN102755541A Plaster for treating scapulohumeral periarthritis due to malnutrition of tendons and channels
10/31/2012CN102755537A External Chinese patent medicine for treating lumbocrural pains and application of external Chinese patent medicine
10/31/2012CN102755497A Fractured tendon and bone reunion cream
10/31/2012CN102755496A Traditional Chinese medicine for blood stasis type scapulohumeral periarthritis
10/31/2012CN102755488A Traditional Chinese medicine composition for treating bone fracture
10/31/2012CN102755484A Stasis-removing bonesetting ointment
10/31/2012CN102755470A Cataplasm for treating cancer pain and preparation method thereof
10/31/2012CN102755469A Externally-used plaster for treating scapulohumeral periarthritis caused by phlegmatic hygrosis
10/31/2012CN102755452A Special-effect hemostasis fracture-healing powder
10/31/2012CN102755437A Plaster for treating scapulohumeral periarthritis
10/31/2012CN102755436A External use drug for treating rheumatoid arthritis and preparation method thereof
10/31/2012CN102755410A Bone setting and blood circulation invigorating medicament for treating bone fracture
10/31/2012CN102755406A Eucommia ulmoides oral solution and preparation method thereof
10/31/2012CN102755401A Lumbar disc herniation rehabilitating medicine
10/31/2012CN102755392A Externally-used plaster for relieving pain caused by femoral head necrosis
10/31/2012CN102755389A Natural Yao medicine specially used for curing gout
10/31/2012CN102755378A Chinese medicinal composition for preventing and treating osteoporosis and preparation method thereof
10/31/2012CN102755374A Acceleration agent of calcium absorption
10/31/2012CN102755371A Traditional Chinese medicine for adjuvantly treating amputated limb and finger replantation
10/31/2012CN102755368A Bone setting traditional Chinese medicine and preparation method thereof
10/31/2012CN102755320A Medicine composition and healthcare food for treating arthritis
10/31/2012CN102755315A Application of ginkgoneolic acid in preparing medicines for treating immunological diseases
10/31/2012CN102755309A Application of cajanin to preparation of medicament for treating or preventing caput femoris necrosis
10/31/2012CN102755295A Medicine composition containing limaprost with improved stability and preparation method thereof
10/31/2012CN102754827A Food for hyperuricemia
10/31/2012CN102754825A Health food for preventing gout
10/31/2012CN102327420B Chinese medicinal composition for setting bones and replenishing muscles and ligaments
10/31/2012CN102188496B Chinese medicine for treating ankylosing spondylitis and preparation method thereof
10/31/2012CN102106801B Natural fatty acid ester peroxide decubitus prevention and treatment product and preparation method thereof
10/31/2012CN102038858B Preparation method of Chinese herbal composition with effects of invigorating Qi and nourishing blood
10/31/2012CN102028872B Orally-taken traditional Chinese medicine for treating acute lumbar muscle sprain and preparation method thereof
10/31/2012CN101969951B Method of compound in preparing medicine for treating arthritis
10/31/2012CN101879250B Arthralgia relief gel paste and preparation method
10/31/2012CN101563365B Anti-IL-6 monoclonal antibodies and uses thereof
10/30/2012US8299030 Peptide-based compounds
10/30/2012CA2528706C Compounds inhibiting the binding of sap for treating osteoarthritis
10/30/2012CA2482080C Vitamin d compounds for use in improving bone strength in pigs
10/30/2012CA2454341C Plasma protein matrices and methods for their preparation
10/30/2012CA2448302C Lipoxin compounds
10/26/2012WO2012144676A1 Chemokine expression regulator
10/26/2012WO2012144661A1 Aromatic heterocyclic derivative having trpv4-inhibiting activity
10/26/2012WO2012144478A1 Tetrahydrothiazepine derivative
10/26/2012WO2012144376A1 Therapeutic or prophylactic agent for osteoarthritis
10/26/2012WO2012143872A1 Phaleria macrocarpa extract, extraction process and its use as cholesteryl ester transferase protein (cetp) inhibitor
10/26/2012WO2012143324A1 Cartilage product
10/26/2012WO2012118309A3 Pyrazole derivatives, preparation method thereof, and composition for preventing and treating osteoporosis containing same
10/26/2012WO2012110636A3 Carrier peptides for cell delivery
10/26/2012WO2012103240A3 Chimeric il-1 receptor type i agonists and antagonists
10/26/2012CA2833571A1 Method of drug delivery for pth, pthrp and related peptides
10/25/2012US20120271361 Functionalized Nanodiamond Reinforced Biopolymers
10/25/2012US20120270952 Method for enhancing the bioavailability of ospemifene
10/25/2012US20120270951 Novel anti-inflammatory cyclooxygenase inhibitors
10/25/2012US20120270897 Acetylene derivatives of 5-phenyl-pyrazolopyridine, preparation thereof, and therapeutic use thereof
10/25/2012US20120270892 Aminopyrimidine Kinase Inhibitors
10/25/2012US20120270881 Conformationally constrained, fully synthetic macrocyclic compounds
10/25/2012US20120270878 Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas
10/25/2012US20120270876 Treatment of Conditions Through Pharmacological Modulation of the Autonomic Nervous System
10/25/2012US20120270874 Biaryl Compositions and Methods for Modulating a Kinase Cascade
10/25/2012US20120270870 Indazole and Pyrazolopyridine Compounds As CCR1 Receptor Antagonists
10/25/2012US20120270868 Rho kinase inhibitors
10/25/2012US20120270862 1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties
10/25/2012US20120270845 Compositions and Methods for Treating Chronic Inflammation and Inflammatory Diseases
10/25/2012US20120270838 Spiroimidazolone derivative
10/25/2012US20120270825 Salix extract, its use and formulations containing it
10/25/2012US20120270819 Use of compounds with sglt-1/sglt-2 inhibitor activity for producing medicaments for treatment of bone disease
10/25/2012US20120270809 Human transmembrane proteins
10/25/2012US20120270787 Compounds having peptides conjugated to bone targeting moieties and methods of making and using thereof
10/25/2012US20120270770 Anti-angiogenic peptides and their uses
10/25/2012US20120270769 Methods of using macrocyclic inhibitors of serine protease enzymes
10/25/2012US20120269912 Compositions and methods of treatment that include plant extracts
10/25/2012US20120269892 Implantable compositions and methods for preparing the same
10/25/2012US20120269873 Flexible Bone Composite
10/25/2012US20120269865 Nutritional composition for promoting gut microbiota balance and health
10/25/2012US20120269838 Carrier conjugates of il-23-peptides and their induced antibodies
10/25/2012US20120269831 Substituted pyrido[2,3-d]pyrimidin-7(8h)-ones and therapeutic uses thereof
10/25/2012US20120269824 Therapeutic human anti-il-1r1 monoclonal antibody
10/25/2012US20120269819 Human Anti-IFN-gamma Neutralizing Antibodies as Selective IFN-gamma Pathway Inhibitors
10/25/2012US20120269809 TNFalpha-Neutralizing Antibodies
10/25/2012US20120269808 Methods and compositions for modulating tweak and fn14 activity
10/25/2012US20120269797 Method for inhibiting the maturation of dendritic cells
10/25/2012US20120269795 Humanized recombinant uricase and mutants thereof
10/25/2012US20120269787 Systemic, allogenic stem cell therapies for treatment of diseases in equines
10/25/2012US20120269786 Systemic, allogenic stem cell therapies for treatment of diseases in felines
10/25/2012US20120269785 Systemic, allogenic stem cell therapies for treatment of diseases in canines
10/25/2012US20120269765 Cytokine compositions and methods of use thereof
10/24/2012EP2514752A1 Epothilone compounds, preparation method and use thereof
10/24/2012EP2513111A1 Mk2 inhibitors
10/24/2012EP2513109A1 Heterocyclic compounds and their uses
10/24/2012EP2512432A1 Injectable compositions for intra-articular use combining a viscosupplementation agent and a fibroblast growth medium
10/24/2012CN102753548A Fused heteroaromatic pyrrolidinones
10/24/2012CN102753190A Blood uric acid level lowering agent
1 ... 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 ... 820